BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/18/2020 5:58:43 AM | Browse: 651 | Download: 1517
 |
Received |
|
2020-05-26 11:57 |
|
Peer-Review Started |
|
2020-05-25 16:21 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-06-09 09:50 |
|
Revised |
|
2020-09-29 11:50 |
|
Second Decision |
|
2020-11-02 09:59 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2020-11-05 19:30 |
|
Articles in Press |
|
2020-11-05 19:30 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2020-11-14 02:07 |
|
Typeset the Manuscript |
|
2020-12-14 05:19 |
|
Publish the Manuscript Online |
|
2020-12-18 05:58 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
HIPPOCRATES<Sup>®</Sup> project: A proof of concept of a collaborative program for hepatitis C virus micro-elimination in a prison setting
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Rui Gaspar, Rodrigo Liberal, Jorge Tavares, Rui Morgado and Guilherme Macedo |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Rui Gaspar, MD, Doctor, Doctor, Department of Gastroenterology, Centro Hospitalar de São João, NA, Porto 4200, Portugal. ruilopesgaspar@gmail.com |
| Key Words |
Hepatitis C infection; Treatment; Prison setting; Direct-acting antiviral agents; Microelimination; |
| Core Tip |
Hepatitis C is now a curable infectious disease with high rates of cure reaching almost 100% with the use of direct antiviral agents. World Health Organization defined the aim of achieving hepatitis C virus elimination by 2030. In the first phase, patients identified with hepatitis C virus infection were treated. Although, to achieve this ambitious goal, we have to reach difficult to access groups, as persons who inject drugs and prisoners. We developed a strategy where a medical team (2-3 doctors) from the hospital went to prison and were responsible to do the outpatient clinics, liver elastography and give the medication on-site, increasing the access to care by avoiding any need to move the patients outside the prison. This was so successful, reaching 99% of sustained virological response in a difficult to treat cohort, that a national program was created implementing our strategy. Therefore, in Portugal, every prisoner has access to treatment inside the prison. |
| Publish Date |
2020-12-18 05:58 |
| Citation |
Gaspar R, Liberal R, Tavares J, Morgado R, Macedo G. HIPPOCRATES<Sup>®</Sup> project: A proof of concept of a collaborative program for hepatitis C virus micro-elimination in a prison setting. World J Hepatol 2020; 12(12): 1314-1325 |
| URL |
https://www.wjgnet.com/1948-5182/full/v12/i12/1314.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v12.i12.1314 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
